223 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

« prev | Page of 5 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NR3C1Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Expressed in all
NR3C2Nuclear receptor subfamily 3, group C, member 2Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
OPRM1Opioid receptor, mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
P2RY12Purinergic receptor P2Y, G-protein coupled, 12Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PAHPhenylalanine hydroxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Group enriched
PDE5APhosphodiesterase 5A, cGMP-specificEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
PDE7APhosphodiesterase 7AEnzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
PDE8BPhosphodiesterase 8BDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enriched
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
PGRProgesterone receptorCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Group enriched
PLA2G1BPhospholipase A2, group IB (pancreas)Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
PLA2G4APhospholipase A2, group IVA (cytosolic, calcium-dependent)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Mixed
PLATPlasminogen activator, tissueCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Mixed
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PNLIPPancreatic lipaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
POLA1Polymerase (DNA directed), alpha 1, catalytic subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
POLBPolymerase (DNA directed), betaEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PRDX5Peroxiredoxin 5Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted intracellular proteins
Expressed in all
PRKAA1Protein kinase, AMP-activated, alpha 1 catalytic subunitEnzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
PRKAB1Protein kinase, AMP-activated, beta 1 non-catalytic subunitFDA approved drug targets
Predicted intracellular proteins
Expressed in all
PROCProtein C (inactivator of coagulation factors Va and VIIIa)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
PROS1Protein S (alpha)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
PSMB1Proteasome (prosome, macropain) subunit, beta type, 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB10Proteasome (prosome, macropain) subunit, beta type, 10Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB8Proteasome (prosome, macropain) subunit, beta type, 8Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMB9Proteasome (prosome, macropain) subunit, beta type, 9Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PSMD1Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
PTGS1Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
PTGS2Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
RARBRetinoic acid receptor, betaCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Mixed
RARGRetinoic acid receptor, gammaCancer-related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
Tissue enhanced
RRM1Ribonucleotide reductase M1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
RXRARetinoid X receptor, alphaCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Expressed in all
RYR1Ryanodine receptor 1 (skeletal)Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
SCN2ASodium channel, voltage-gated, type II, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SERPINB2Serpin peptidase inhibitor, clade B (ovalbumin), member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
SERPINC1Serpin peptidase inhibitor, clade C (antithrombin), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin peptidase inhibitor, clade D (heparin cofactor), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SISucrase-isomaltase (alpha-glucosidase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
SIGMAR1Sigma non-opioid intracellular receptor 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
SIRT5Sirtuin 5FDA approved drug targets
Predicted intracellular proteins
Expressed in all
SLC12A1Solute carrier family 12 (sodium/potassium/chloride transporter), member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A3Solute carrier family 12 (sodium/chloride transporter), member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A5Solute carrier family 12 (potassium/chloride transporter), member 5FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC22A8Solute carrier family 22 (organic anion transporter), member 8FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC5A2Solute carrier family 5 (sodium/glucose cotransporter), member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC6A1Solute carrier family 6 (neurotransmitter transporter), member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
SMSSpermine synthaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Expressed in all
SNAP25Synaptosomal-associated protein, 25kDaFDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
SOAT1Sterol O-acyltransferase 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched

« prev | Page of 5 | next »